SQUADRITO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.798
EU - Europa 4.229
AS - Asia 893
SA - Sud America 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 9.935
Nazione #
US - Stati Uniti d'America 4.760
IE - Irlanda 1.360
SE - Svezia 1.183
CN - Cina 777
IT - Italia 475
UA - Ucraina 372
DE - Germania 309
FI - Finlandia 166
GB - Regno Unito 104
PL - Polonia 102
IN - India 86
BE - Belgio 53
FR - Francia 41
CA - Canada 38
RU - Federazione Russa 19
AT - Austria 13
IR - Iran 11
NL - Olanda 11
VN - Vietnam 8
CZ - Repubblica Ceca 5
ES - Italia 5
CL - Cile 4
SG - Singapore 4
BD - Bangladesh 3
CH - Svizzera 3
RO - Romania 3
AU - Australia 2
EU - Europa 2
IL - Israele 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
EE - Estonia 1
EG - Egitto 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
SC - Seychelles 1
VE - Venezuela 1
Totale 9.935
Città #
Dublin 1.360
Chandler 963
Jacksonville 803
Nyköping 656
Ashburn 473
Beijing 304
Princeton 201
Medford 189
Messina 170
Ann Arbor 163
Cambridge 150
Des Moines 150
Boardman 122
Warsaw 102
Dearborn 96
New York 78
Woodbridge 66
Wilmington 62
Jinan 58
Brussels 53
Rome 45
Shenyang 43
Nanjing 42
Hebei 40
Hyderabad 38
Pune 37
San Mateo 37
Bremen 35
Ottawa 35
Nuremberg 34
Houston 33
Haikou 32
Lancaster 29
Ningbo 26
Guangzhou 25
Seattle 25
Tianjin 25
Zhengzhou 24
Rosolini 21
Los Angeles 20
Hangzhou 19
Nanchang 19
Taizhou 18
Catania 16
Auburn Hills 14
Vienna 13
Helsinki 12
Changsha 11
Fuzhou 11
Lanzhou 11
Ardabil 10
Norwalk 10
Avola 9
Tappahannock 9
Washington 9
Augusta 8
Dong Ket 8
Falls Church 8
Hefei 7
Jiaxing 7
Lappeenranta 7
Leawood 7
Milan 7
Tilburg 7
Monmouth Junction 6
Scandicci 6
Sortino 6
Taiyuan 6
Lamezia Terme 5
Qingdao 5
Caltagirone 4
Madrid 4
Mumbai 4
Novokuznetsk 4
Pachino 4
Regensburg 4
Saint Petersburg 4
Strasbourg 4
Amsterdam 3
Belpasso 3
Bucharest 3
Changle 3
Chicago 3
Clearwater 3
Redwood City 3
Siculiana 3
Singapore 3
Bari 2
Chengdu 2
Culver City 2
Dalmine 2
Edinburgh 2
Frontone 2
Gravina di Catania 2
Impruneta 2
Kemerovo 2
Kunming 2
Lamézia 2
Las Vegas 2
London 2
Totale 7.241
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 268
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 122
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 104
Atrial fibrillation in patients with cirrhosis 96
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 94
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 93
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 92
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 87
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 86
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 85
Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension 84
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 83
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 81
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 79
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 79
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 77
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 75
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 72
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 72
null 70
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 70
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 70
HCV NS5A mutations and response of chronic hepatitis to alpha interferon. 68
Inhibition of nuclear factor-kappa B activation by IRFI 042, protects against endotoxin-induced shock 68
17 beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat 68
Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant. 67
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 66
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 66
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 65
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 65
G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS 64
Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies 64
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 64
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 64
ANTIBODIES AGAINST INTERCELLULAR-ADHESION MOLECULE-1 PROTECT AGAINST MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT 63
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 63
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 63
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 63
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury 62
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 62
Abnormal left ventricular global strain during exercise-test in young healthy smokers 61
Endotoxin tolerance impairs a pertussis-toxin-sensitive G- protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats 60
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 60
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 60
Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension] 59
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury 59
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 59
CENTRAL DIPSOGENIC EFFECT OF SYNTHETIC RAT ATRIAL NATRIURETIC POLYPEPTIDE IN NORMOTENSIVE RATS 59
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 59
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 59
Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. 58
Clinical virology of hepatitis B virus infection 58
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 58
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 58
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 58
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 58
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 58
Effect of sulfatide on acute lung injury during endotoxemia in rats 57
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 57
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 57
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 57
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 56
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 56
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 56
Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease 55
PARTICIPATION OF TUMOR-NECROSIS-FACTOR AND NITRIC-OXIDE IN THE MEDIATION OF VASCULAR DYSFUNCTION IN SPLANCHNIC ARTERY- OCCLUSION SHOCK 55
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 55
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 55
Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C 54
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock 54
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 54
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 54
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 54
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience 54
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 53
Inhibition of tumour necrosis factor and reversal of endotoxin- induced shock by U-83836E, a 'second generation' lazaroid in rats 53
Cardiovascular effects of raloxifene hydrochloride 53
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 53
Efferent vagal fibre stimulation blunts nuclear factor-kappa B activation and protects against hypovolemic hemorrhagic shock 53
Beneficial effect of raxofelast, an hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury 52
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury 52
Protective effects of Cyclosporin-A in splanchnic artery occlusion shock 52
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 52
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 52
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 52
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 52
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 51
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 51
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 50
Evidence for a role of nuclear factor-kappa B in acute hypovolemic hemorrhagic shock 50
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 50
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 50
Inhibition of lipid peroxidation reduces the inflammatory response and increases early-immediate genes expression in carbon tetrachloride-induced rat liver injuri. 48
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 48
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 48
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 48
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 48
Nutraceuticals: A New Challenge against Cadmium‐Induced Testicular Injury 48
Psychosocial Stress and chronic hepatitis C virus (HCV). 47
Oxidative stress causes nuclear Factor-kappa B activation in acute hypovolemic hemorrhagic shock 47
Totale 6.458
Categoria #
all - tutte 39.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 0 8
2019/20201.418 224 104 3 91 9 105 172 190 17 262 220 21
2020/20211.301 146 16 351 56 69 130 31 144 93 124 94 47
2021/20221.482 25 168 36 42 97 7 99 59 29 297 171 452
2022/20233.924 286 386 165 283 287 407 67 230 1.611 26 132 44
2023/20241.195 76 139 62 121 82 223 14 272 4 86 76 40
Totale 10.236